The COVID-19 Pandemic will turn 3 this year, and during that time, cancer has not waited. Cancer care has still been disrupted, and tackling the...Read More
The following is a letter from the Breathe Hope Research Group Dear Canadian Lung Cancer Patients, A group of lung cancer patients is conducting this...Read More
Below is a statement from the Ontario Health Coalition regarding the Ontario Government’s decision to use private clinics to address the...Read More CCSN News, News
January is Cervical Cancer Awareness Month, and so to raise awareness, let’s talk about HPV vaccination. The Human papillomavirus, HPV, is the...Read More
The need for accurate data in treating cancer is essential and its impact is felt across healthcare in general. Clinical Trials Ontario (CTO) has been...Read More
In last month’s newsletter, the Canadian Cancer Survivor Network outlined its work with our Cancer Can’t Wait Virtual Action Weeks with...Read More Cancer Can't Wait, News
- In-person All Party Cancer Caucus meetings resume in Ontario
- Start breast cancer screening at 40, add supplemental screening, says Dense Breast Canada Doctor
- How Breast Density Makes Cancer Harder to Find
- If You Want to Get Screened for Lung Cancer in Ontario, Be Prepared to Travel
- Feb06Better Breathing Week
Better Breathing Week is the Lung Health Foundation’s marquee annual event and represents their work in the national lung health space. Celebrating 40 years, this year’s conference will bring together a community of healthcare professionals, people with lived experience, policy makers and more for a week filled with: Informative educational sessions Thought-provoking ideas for practice change Powerful discussions on key policy issues impacting CanadiansView Event
- Feb07Rally for public health care at Trudeau-Premiers meeting
Prime Minister Justin Trudeau and the Premiers will be discussing health care on February 7 in Ottawa. Join us outside that meeting to send a loud message to our leaders: our public health care system needs to be protected and expanded. 12:00-1:00 PM ET Terry Fox Statue Wellington & Metcalfe, OttawaView Event
- Feb07Lung Health Foundation’s Better Breathing Week
Registration for the Lung Health Foundation’s Better Breathing Week is now OPEN. An educational adventure where you can make new connections and help create a world where everyone can breathe better. Sessions run February 7-10, 2023. Here’s a sneak peak at some of our Friday highlights featuring speakers from across Canada: Patient-Oriented Research and Its Implications on Indigenous Respiratory Health with Malcolm King, PhD, FCAHS,View Event
- Feb08PMPRB Webinar: CompassRx, 8th Edition
This event is put on by the PMPRB NPDUIS As part of the National Prescription Drug Utilization Information System (NPDUIS) research initiative, the Patented Medicine Prices Review Board has just released the seventh edition of CompassRx, a series that monitors and analyzes the cost pressures driving changes in prescription drug expenditures in Canadian public drug plans. This edition provides insight into the factors driving theView Event
- Feb09What to say when you don’t know what to say: Navigating Challenging Conversations
This event is put on by the West Island Cancer Wellness Centre. Sometimes, we just do not know what to say to someone living with cancer. We can feel as though we might say something wrong, so better to say nothing. Sound familiar? If so, this amazing Zoom into Wellness session is for you.View Event
- CTO’s decentralized clinical trials survey
CTO launched a survey related to potential participants' thoughts and preferences related to decentralized or hybrid clinical trials. This type of survey has not yet been done in Canada and will provide us with evidence about how Canadians may prefer to participate in clinical trials. The data will help inform us and tell us how we might best work with our community around these preferences. We collaborated with our College of Lived Experience to develop the survey. We plan to share results with the community and to develop tools/resources based on these results. The survey is open to any Canadian over 18 years - it doesn't matter what your background is, if you've participated in a clinical trial or not, if you work in research, etc.Participate Now
- Assessing Patient Awareness and Satisfaction about the Information Received by Health-Care Providers on the Potential Risks of Cancer-Associated Venous Thromboembolism and Anticoagulation
A Global Initiative for World Thrombosis Day 2022. This survey has been created to evaluate patient knowledge and satisfaction with the information given to them regarding the potential risks of cancer- associated venous thromboembolism and anticoagulation.THROMBOSISParticipate Now
- Mesothelioma Applied Research Foundation Research Funding Opportunity
Thanks to the generous support of our patients, families, caregivers, corporate supporters, and the many friends of the Mesothelioma Applied Research Foundation, they are pleased to announce that the 2022 research funding grant cycle is now open accepting pre-application letters of intent (LOI) until 11:59 PM ET Monday, November 21, 2022. their research grant program offers $100,000 grants for two years ($50,000 per year). Please read the below before applying Additional information to be included in the LOI:
- All applications need to focus on pleural and/or peritoneal mesothelioma and should address at least one of the 2022 Areas of Interest (listed below).
- All projects must be feasible within the timeline and budgetary constraints of the current LOI.
- All other funding, overlapping and/or supplemental funding, for the proposed project should be disclosed as part of the application.
- Junior investigators with an interest in a carrier focus in mesothelioma are strongly encouraged to apply to this RFA. As part of their application, they should identify an established mesothelioma researcher as their mentor and provide a career development and mentorship plan in the context of their application.
- Novel therapies for mesothelioma for both pleural and peritoneal, especially targeted therapies, combination immunotherapy, cellular therapy, and virotherapy.
- Health-related quality of life assessment incorporating the social determinants of health (SDOH) specific to mesothelioma patient care, side effect management, mental health care impact on patient and/or caregiver outcomes, and other related topics.
- Novel strategies for screening and early detection.
- Novel strategies for risk assessment and prognosis stratification.
- Immune mediated complications of immunotherapy in mesothelioma (monitoring, early detection, and management).
- Improving personalization of therapies (gender and racial differences, targeted therapies, and predictive biomarkers).
- Mechanisms of treatment resistance/failure.
- Mesothelioma biology and etiology (disease-defining molecular pathways, cellular biology, and/or tumor microenvironment).
- Rare Disease survey from the Canadian Organization for Rare Disorders
The Canadian Organization for Rare Disorders need input on the impact of RARE DISEASES on you and your family, as well as YOUR PERSPECTIVES on how Canadian health systems can improve access to rare disease medicines. COMPLETE THE SURVEY BY NOVEMBER 14: In ENGLISH here: https://tinyurl.com/CORD2022EnglishSurvey In FRENCH here: https://tinyurl.com/CORD2022FrenchSurvey THE SURVEY IS FOR PATIENTS AND CAREGIVERS: If you are a Canadian or resident in Canada affected by rare diseases (patients and caregivers), please take a few minutes to complete this confidential survey conducted by Ipsos Canada on behalf of the Canadian Organization for Rare Disorders (CORD). This survey will be available for completion until Monday, November 14, 2022.Participate Now
- Chronic Myeloid Leukemia Treatment | Needs Assessment
OncologyEducation is evaluating their members’ needs on the topic of Chronic Myeloid Leukemia Treatment and they want to hear from you! Please complete this short survey to help us plan and develop future learning activities. All data will remain secure and confidential. Respond for a chance to win one of four $25 e-Visa Gift Cards.Participate Now
Cancer Journey Stories
I first learned that I had prostate cancer from my urologist in 1995, and he told me that I actually had a very aggressive cancer. I had been to my family doctor in 1992 and 1993 for my annual checkup, which was fine; no mention was ever made to me about having a PSA blood test, but I was given a digital rectal exam. SomehowRead More
Thomas Vicars was 60-years-old when he was diagnosed with prostate cancer. His prostate-specific antigen (PSA), which had been monitored throughout his 50s, had been rising for several years. After it went up to a little over 16, a biopsy confirmed prostate cancer. Thomas began looking into treatment options and wanted to go with brachytherapy, but was turned down due to his diabetes. This left surgeryRead More